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Abstract  25 
Burkholderia cepacia complex (Bcc) species are a group of Gram-negative opportunistic 26 
pathogens that infect the airways of cystic fibrosis patients, and occasionally they infect other 27 
immunocompromised patients. Bcc bacteria display high-level multidrug resistance, and 28 
chronically persist in the infected host while eliciting robust inflammatory responses. Studies 29 
using macrophages, neutrophils and dendritic cells, combined with advances to genetically 30 
manipulate these bacteria have increased our understanding of the molecular mechanisms of 31 
virulence in these pathogens and the molecular details of cell-host responses triggering 32 
inflammation. This article discusses our current view of the intracellular survival of B. 33 
cenocepacia within macrophages. 34 
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 39 
Introduction 40 
 The Burkholderia cepacia complex (Bcc) comprises a subset of Burkholderia species that 41 
cause respiratory infection in patients with cystic fibrosis (CF) (Coenye and Vandamme 2003; 42 
Vandamme and Dawyndt 2011). The Bcc species are opportunistic pathogens acquired from the 43 
environment, which can survive intracellularly in human respiratory epithelial cells, neutrophils, 44 
macrophages, and amoebae (Loutet and Valvano 2010; Saldías and Valvano 2009). Bcc clinical 45 
infections elicit inflammatory responses leading to rapid deterioration of lung function in CF 46 
patients. Some species, particularly, B. cenocepacia, cause in CF patients a lethal necrotizing 47 
pneumonia associated with sepsis (Cepacia syndrome). Dysregulated inflammatory responses 48 
upon B. cenocepacia infection originate from activation of the NLRP3 and pyrin inflammasomes 49 
(Gavrilin et al. 2012; Rosales-Reyes et al. 2012a; Xu et al. 2014). In this article, I will focus on 50 
our current understanding of the molecular mechanisms of intracellular survival of Bcc bacteria, 51 
especially B. cenocepacia, and the inflammatory response of infected macrophages. For 52 
additional information, the reader should consult excellent recent reviews (Bazzini et al. 2011; 53 
Cullen and McClean 2015; Drevinek and Mahenthiralingam 2010; Ganesan and Sajjan 2011; 54 
Leitão et al. 2010; McClean and Callaghan 2009; Parkins and Floto 2015; Vial et al. 2011). 55 
 56 
Bcc bacteria - intracellular survivors in professional phagocytes and epithelial 57 
cells 58 
 Research over the past two decades has demonstrated that at least some species of the Bcc 59 
survive intracellularly in free-living amoebae (Anacarso et al. 2010; Lamothe et al. 2004; 60 
Landers et al. 2000; Marolda et al. 1999), murine and human macrophages in culture (Lamothe 61 
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et al. 2007; Lamothe and Valvano 2008; Martin and Mohr 2000; Saini et al. 1999), and epithelial 62 
cells (Burns et al. 1996; Duff et al. 2006; Keig et al. 2002; Moura et al. 2008; Sajjan et al. 2006; 63 
Schwab et al. 2002; Taylor et al. 2010). The laboratory observations have also been recapitulated 64 
in the human host, as demonstrated in a recent study that investigated resected lungs of Bcc-65 
infected CF patients undergoing transplant (Schwab et al. 2014). These authors observed that in 66 
contrast to Pseudomonas aeruginosa, Bcc bacteria were predominantly identified as single cells 67 
or small clusters within phagocytes and mucus, but not as biofilm-like structures. 68 
 Engulfed B. cenocepacia in murine macrophages reside on a membrane-bound compartment 69 
with a maturation defect (Fig. 1) (Andrade and Valvano 2014; Flannagan et al. 2012; Huynh et al. 70 
2010; Keith et al. 2009; Lamothe et al. 2007; Maloney and Valvano 2006; Rosales-Reyes et al. 71 
2012b).  Phagosomes containing B. cenocepacia transiently recruit early endosome autoantigen 72 
(EEA1) and Rab5, and synthesize phosphatidylinositol-3-phosphate, indicating that the bacterial 73 
containing vacuoles progress normally to the early phagosomal stage (Huynh et al. 2010; 74 
Lamothe et al. 2007). However, these vacuoles exhibit a significant delay in the accumulation of 75 
the late endosome/lysosome marker LAMP-1 (Lamothe et al. 2007) while acquiring CD63 and 76 
Rab7 (Huynh et al. 2010). During their arrested maturation, the bacterial containing vacuole 77 
remain in contact with newly formed endosomes and maintain a luminal pH around 6.4 78 
(Lamothe et al. 2007). Delay in acidification correlates with delayed recruitment of the 16-kDa 79 
subunit of the phagosomal vATPase onto the membrane of the bacterial containing vacuole 80 
(Rosales-Reyes et al. 2012b). Further, the arrested phagosome has a delay to assemble the 81 
NADPH oxidase complex (Keith et al. 2009; Rosales-Reyes et al. 2012b). Fluorescence recovery 82 
after photobleaching and use of a probe that detects Rab7-guanosine triphosphate revealed that 83 
the Rab7 recruited to the bacterial containing vacuole is inactive, suggesting a potential 84 
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mechanism for the inability of these vacuoles to fuse with lysosomes as a consequence of Rab7 85 
defect (Huynh et al. 2010). The B. cenocepacia-containing phagosome also acquires LC3 86 
(Abdulrahman et al. 2012; Abdulrahman et al. 2011; Al-Khodor et al. 2014)(Kevin, Torres and 87 
Valvano, unpublished), a marker for autophagy, and the intracellular infection downregulates the 88 
expression of other components involved in autophagy (Abdulrahman et al. 2012; Abdulrahman 89 
et al. 2011) suggesting the possibility that B. cenocepacia survives in an arrested autophagosome 90 
(Fig. 1). A recent study reported that B. cenocepacia also escape the bacteria-containing 91 
vacuoles, as determined by the apparent recruitment of galectin-3 (Al-Khodor et al. 2014), a 92 
marker for vacuole disruption. Attempts to repeat this work in our laboratory have failed to 93 
clearly demonstrate galectin-3 recruitment and colocalization with intracellular B. cenocepacia 94 
(Torres-Bustos and Valvano, unpublished). 95 
 B. cenocepacia and B. multivorans are the Bcc species most commonly isolated from CF 96 
patients (Drevinek and Mahenthiralingam 2010). Despite that most research groups have focused 97 
on the study of B. cenocepacia, the incidence of B. multivorans infections has steadily increased 98 
and B. multivorans is now the most prevalent Bcc strain infecting CF patients in North America 99 
and also the most common species infecting patients with chronic granulomatous disease 100 
(Zelazny et al. 2009). B. multivorans infects human lung epithelial cells (Duff et al. 2006; Moura 101 
et al. 2008), monocytes (Zelazny et al. 2009), and dendritic cells (Macdonald and Speert 2008). 102 
B. multivorans isolates survive and slowly replicate within murine macrophages in a manner 103 
similar to B. cenocepacia (Schmerk and Valvano 2013). In contrast, the B. multivorans and B. 104 
cenocepacia strains do not replicate within human THP-1 macrophages and their numbers 105 
diminished marginally after 48 hours of infection (Schmerk and Valvano 2013).  106 
 6 
 Similar survival and intracellular replication of B. cenocepacia and B. multivorans in 107 
macrophages does not preclude differences in their trafficking properties after engulfment. 108 
Indeed, whereas B. cenocepacia delays phagosomal maturation in murine macrophages (Huynh 109 
et al. 2010; Lamothe et al. 2007) the endocytic trafficking pattern of B. multivorans does not 110 
show a maturation arrest of the bacteria-containing vacuole (Schmerk and Valvano 2013). 111 
Therefore, B. cenocepacia and B. multivorans appear to survive within immune cells using 112 
different strategies. These differences have become useful to investigate factors associated to 113 
phagosomal arrest using B. multivorans recombinant strains expressing B. cenocepacia genes 114 
(Andrade and Valvano 2014). 115 
 116 
To replicate...or not replicate - B. cenocepacia and the gentamicin protection 117 
assay 118 
 Intracellular Bcc in amoebae and macrophages are viable and metabolically active (Marolda 119 
et al. 1999; Saini et al. 1999). However, reliable quantification of the intracellular infection is 120 
difficult due to the extreme resistance of Bcc bacteria to aminoglycoside antibiotics (Saini et al. 121 
1999). This precludes using the classical gentamicin protection assay traditionally employed to 122 
quantify intracellular bacteria (Elsinghorst 1994; Isberg and Falkow 1985). Antibiotic treatment 123 
of Bcc-infected macrophages requires large doses of kanamycin in combination with ceftazidime, 124 
which at best do not efficiently kill all extracellular bacteria (Burns et al. 1996; Saini et al. 1999), 125 
and may cross the cell membrane reaching the intracellular bacteria. There are no reports 126 
systematically assessing whether very high antibiotic concentrations used in some studies (Al-127 
Khodor et al. 2014) directly affect the macrophages. Preliminary experiments in our laboratory 128 
indicate that high concentrations of ceftazidime dramatically alter the bacterial uptake and 129 
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trafficking (Torres-Bustos and Valvano, unpublished). An efficient protocol for constructing 130 
markerless gene deletions in B. cenocepacia (Flannagan et al. 2008) allowed the creation of 131 
gentamicin-sensitive strains of B. cenocepacia in which the genes encoding an AmrAB-OprA-132 
like efflux pump were deleted (Hamad et al. 2010). B. cenocepacia strains carrying this deletion 133 
are hypersensitive to gentamicin, allowing the use of low concentrations of gentamicin to 134 
effectively kill extracellular bacteria and demonstrating that engulfed bacteria can replicate 135 
slowly over 24-48 hours post infection (Hamad et al. 2010).  136 
 137 
Bacterial entry and survival in macrophages 138 
 Very little is known about bacterial factors involved in entry and intramacrophage bacterial 139 
survival of B. cenocepacia. The O-antigen moiety of the lipopolysaccharide molecule is 140 
associated with reduced bacterial engulfment by macrophages (Saldías et al. 2009; Schmerk and 141 
Valvano 2013). However, the macrophage receptor involved with bacterial recognition remains 142 
unknown. Recently, Eierhoff et al. (2014) uncovered a novel mechanism for the entry of P. 143 
aeruginosa into epithelial cells that occurs independently of actin polymerization and involves 144 
the interaction of a bacterial surface lectin LecA with a membrane glycolipid receptor. B. 145 
cenocepacia produced several LecA-like surface lectins (Šulák et al. 2011), suggesting that a 146 
similar mechanism may operate in these bacteria for entry in epithelial cells and perhaps also 147 
macrophages.   148 
 Using the rat agar bead model of chronic lung infection revealed that a B. cenocepacia 149 
transposon mutant carrying an insertion in the mgtC gene was dramatically attenuated (Hunt et 150 
al. 2004), and a subsequent study demonstrated that this mutant fails to delay phagosomal 151 
maturation resulting in rapid targeting of the bacteria-containing vacuole to the lysosomal 152 
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compartment and a compromise in bacterial survival (Maloney and Valvano 2006). MgtC is 153 
essential for the intramacrophage survival of several intracellular bacteria (Alix and Blanc-154 
Potard 2007), a function that was recently attributed to its ability to regulate the bacterial 155 
physiological ATP levels and cytosolic pH (Lee et al. 2013). Furthermore, two sigma factors 156 
controlling the regulation of multiple genes, RpoN and RpoE, are required for the intracellular 157 
survival of B. cenocepacia (Flannagan and Valvano 2008; Saldías et al. 2008), but the specific 158 
gene determinants involved in survival have not been elucidated.  159 
 Factors involved in resistance to oxidative damage play a role in intracellular survival of B. 160 
cenocepacia. Indeed, vacuoles containing a B. cenocepacia mutant unable to produce a melanin-161 
like pigment rapidly traffic to the lysosome, but this process can be halted in the presence of the 162 
NADPH oxidase and nitric oxide inhibitors (Keith et al. 2007). Therefore, melanin-like pigment 163 
production by B. cenocepacia protects intracellular bacteria from oxidative damage. Indeed, the 164 
delay of the bacteria-containing vacuole to incorporate NADPH oxidase components (Keith et al. 165 
2009; Rosales-Reyes et al. 2012b) suggests that B. cenocepacia must escape oxidative damage to 166 
overcome the host cell defensive mechanisms. Bylund et al. (2006) showed that many Bcc 167 
isolates produce large amounts of exopolysaccharide that interfere with the function of human 168 
neutrophils in vitro. These interactions lead to inhibition of neutrophil chemotaxis and 169 
production of reactive oxygen species that are essential components of innate neutrophil-170 
mediated host defences. These authors also provided direct evidence that the exopolysaccharide 171 
inhibits enzymatic generation of ROS in a cell-free system (Bylund et al. 2006).  172 
 B. cenocepacia also produces two Zn+2-dependent metalloproteases, ZmpA and ZmpB, 173 
whose expression is controlled by quorum sensing and the AtsR hybrid sensor kinase (Aubert et 174 
al. 2013; Corbett et al. 2003; Gingues et al. 2005; O'Grady et al. 2012). These proteases can 175 
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cleave and inactivate in vitro antimicrobial peptides involved in innate immunity (Kooi and 176 
Sokol 2009), and are required in vivo for the maturation arrest of the bacteria-containing 177 
vacuoles (Rosales-Reyes et al. 2012a). 178 
 A low molecular protein tyrosine phosphatase, referred to as Dpm (delayed phagosome 179 
maturation), is also required for the phagosome maturation arrest upon macrophage infection 180 
(Andrade and Valvano 2014). Heterologous expression of Dpm in B. multivorans confers to this 181 
bacterium a similar phagosomal maturation delay as found with B. cenocepacia. A mycobacterial 182 
low molecular protein tyrosine phosphatase prevents incorporation of the host vacuolar ATPase 183 
(vATPase) to the vacuole containing Mycobacterium tuberculosis and blocks acidification 184 
(Wong et al. 2011). Therefore, it is conceivable that Dpm could be responsible for the delayed 185 
acidification of the bacteria-containing vacuole by impairing the recruitment of the 16-kDa 186 
subunit of the phagosomal vATPase (Rosales-Reyes et al. 2012b). However, the Dpm 187 
mechanism is unclear since the protein appears to be biochemically inactive in vitro, suggesting 188 
that its contribution to phagosomal maturation arrest must be unrelated to tyrosine phosphatase 189 
activity (Andrade and Valvano 2014). Also, efforts to detect the host cell target of Dpm by co-190 
immunoprecipitation experiments did not afford any reproducible candidates (Andrade and 191 
Valvano, unpublished).    192 
 193 
The role of the B. cenocepacia specialized secretion system in macrophage 194 
survival and inflammation  195 
Bacterial intracellular survival requires in most cases one or more specialized secretory systems 196 
responsible for injecting bacterial molecules into the cytoplasm of eukaryotic cells (Costa et al. 197 
2015; Galán 2009). These molecules target host-signalling pathways, allowing bacteria to 198 
 10 
establish an intracellular niche (Records 2011; van der Heijden and Finlay 2012; Voth et al. 199 
2012). B. cenocepacia expresses one Type 3 (T3SS), two Type 4 (T4SS-1 and T4SS-2), and one 200 
Type 6 (T6SS) secretion systems. A report by Sajjan et al. (2008) concluded that the plasmid 201 
encoded T4SS-1 was required for intracellular survival and replication in macrophages. Using 202 
markers of the classical endocytic pathway in colocalization experiments, these authors showed 203 
that mutant and parental strains reside transiently in early endosomes, but a greater proportion of 204 
the mutant bacteria are targeted for lysosomal degradation. In our laboratory, we have 205 
constructed deletion mutants defective in each of the secretion systems singly and in 206 
combination, including a mutant defective in all the secretion systems (Tolman and Valvano, 207 
unpublished data). Using these mutants, we could not find differences in intracellular survival in 208 
murine macrophages measured as recovered bacteria at 24 h post-infection (Tolman and 209 
Valvano, unpublished data). Therefore, the role of the T4SS and the other secretion systems in 210 
the biology of B. cenocepacia intracellular infection is controversial and requires further 211 
investigation. It is possible that one or more secretion system in B. cenocepacia will be needed 212 
for specific conditions such as survival in different tissues or establishment of infection in non-213 
mammalian hosts, experiments that are currently underway in our laboratory..  214 
 215 
T6SS affects the normal function of small Rho GTPases 216 
The T6SS is a recently recognized secretion system widely spread in Gram-negative pathogenic 217 
(Cascales 2008; Pukatzki et al. 2006; Zoued et al. 2014) and non-pathogenic bacteria (Jani and 218 
Cotter 2010). A distinct feature of the T6SS in comparison with the other secretion systems is its 219 
predominant role for bacterial competition, as most of the identified Type 6 secreted effectors are 220 
directed to inhibit growth of neighbouring bacteria in mixed populations (Russell et al. 2011; 221 
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Russell et al. 2014). In some cases, the same effector targets other bacteria and the eukaryotic 222 
host (Jiang et al. 2014). The B. cenocepacia T6SS is essential for virulence in vivo, as a library of 223 
mutants attenuated for virulence in the rat agar bead model of lung infection (Hunt et al. 2004) 224 
contained three independent transposon mutants in a region that was subsequently identified as a 225 
T6SS gene cluster (Aubert et al. 2008). The T6SS gene expression is negatively regulated by a 226 
global regulator designated AtsR (Aubert et al. 2013). Macrophage infection assays showed that 227 
an atsR mutant induces the formation of actin-mediated cell projections in a process that is T6SS 228 
dependent (Aubert et al. 2008). Surprisingly, the T6SS is not required for the maturation arrest of 229 
the bacteria-containing vacuole (Rosales-Reyes et al. 2012b). Further research established that 230 
intracellular B. cenocepacia expressing the T6SS alter the activation of Rac1 and Cdc42 231 
GTPases by reducing the cellular pool of GTP-bound Rac1 and Cdc42 (Fig. 2) (Flannagan et al. 232 
2012; Rosales-Reyes et al. 2012b). GTPase inactivation requires internalization of viable 233 
bacteria and also inhibits macropinocytosis and phagocytosis (Flannagan et al. 2012). These 234 
effects lead to abnormal actin polymerization causing collapse of lamellipodia and failure to 235 
retract the uropod. The T6SS also prevents the recruitment of soluble subunits of the NADPH 236 
oxidase complex including Rac1 to the membrane of bacteria-containing vacuole membrane, but 237 
is not involved in causing the phagosome maturation arrest (Rosales-Reyes et al. 2012b). We 238 
have recently identified a novel T6SS effector protein, designated as TecA (T6SS effector 239 
protein affecting the cytoskeleton architecture of macrophages), which is required for actin 240 
rearrangements (Aubert and Valvano, unpublished data). Macrophage infection by B. 241 
cenocepacia can result in the T6SS-dependent deamidation of a critical asparagine-41 residue in 242 
the RhoA GTPase (Xu et al. 2014), suggesting that TecA may be effector responsible for the 243 
modification of Rho-family GTPases. 244 
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 245 
T6SS mediates damage of the bacteria-containing vacuole leading to increased 246 
proinflammatory responses 247 
Bcc infections are often persistent and lead to exacerbated inflammatory responses (Downey et 248 
al. 2007; Moura et al. 2008; Ventura et al. 2009). The B. cenocepacia T6SS induces a 249 
proinflammatory response in macrophages, which depends on the activation of the NLRP3 250 
inflammasome and results in the stimulation of IL-1β secretion in a caspase-1-dependent manner 251 
that ultimately leads to cell death by pyroptosis (Rosales-Reyes et al. 2012a). Furthermore, the 252 
T6SS-mediated disruption of the phagosomal membrane allows the escape of proteins secreted 253 
by the T2SS into the macrophage cytoplasm (Rosales-Reyes et al. 2012a), namely the proteases 254 
ZmpA and ZmpB, which may also contribute to proinflammatory signaling (Kooi and Sokol 255 
2009).   256 
 Murine macrophages use the NLRP3 and pyrin inflammasomes together with the host 257 
adapter molecule ASC to detect intracellular B. cenocepacia (Rosales-Reyes et al. 2012a; Xu et 258 
al. 2014). In contrast, detection of intracellular B. cenocepacia in human macrophages requires 259 
pyrin (Gavrilin et al. 2012). The activation of the NLRP3/ASC and pyrin/ASC inflammasomes 260 
also required a functional T6SS (Gavrilin et al. 2012; Rosales-Reyes et al. 2012a; Xu et al. 2014). 261 
Therefore, a model is emerging from all of these studies in murine and human macrophages 262 
indicating the expression of T6SS plays a proinflammatory role, resulting in damage of the 263 
phagosomal membrane with the concomitant release of bacterial mediators of inflammation 264 
accumulated in its lumen. Also, the T6SS causes the modification of RhoA and possibly other 265 
Rho-family GTPases (Xu et al. 2014). The activation of both NLRP3 and pyrin inflammasomes 266 
is not completely elucidated and may not require direct sensing of pathogen molecules (Elliott 267 
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and Sutterwala 2015; Yang et al. 2014), but rather cellular modifications due to the infecting 268 
pathogen, which ultimately contributes to inflammasome activation and host cell death. This 269 
notion correlates well with clinical observations documenting the proinflammatory nature of the 270 
respiratory infection by B. cenocepacia in CF patients.  271 
 272 
Role of the CF transmembrane conductance regulator (CFTR) in B. 273 
cenocepacia intracellular survival 274 
A remarkable observation in the biology of the B. cenocepacia infection in macrophages was the 275 
finding that the maturation arrest of the bacteria-containing vacuoles is greatly exaggerated in 276 
CFTR-defective macrophages than in CFTR-normal macrophages (Lamothe and Valvano 2008). 277 
This suggests that not only defective CFTR, but also viable B. cenocepacia are required for the 278 
altered trafficking phenotype. Therefore, CFTR may play a role in the mechanism of clearance of 279 
the intracellular infection, as B. cenocepacia bacterial cells that localized to the lysosome lost 280 
cell envelope integrity (Lamothe et al. 2007). The suggestion that CFTR is the Cl- ion channel 281 
essential for phagosomal acidification (Di et al. 2006) has been disproved by several groups 282 
(Barriere et al. 2009; Haggie and Verkman 2007; Lamothe and Valvano 2008; Painter et al. 283 
2008; Painter et al. 2010) and therefore cannot explain the delayed maturation arrest of bacteria-284 
containing vacuoles in CFTR-defective macrophages. Additional possibilities to explain how the 285 
CFTR defect enhances the B. cenocepacia intracellular survival have been discussed elsewhere 286 
(Valvano et al. 2012). However, current evidence indicates that defective CFTR leads to 287 
defective autophagy and decreases the clearance of protein aggregates, which in turns leads to 288 
inflammation (Luciani et al. 2010; Luciani et al. 2011; Luciani et al. 2012). Conceivably, 289 
defective autophagy might alter the ability of macrophages to clear the intracellular infection. 290 
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Indeed, several intracellular pathogens reside in vacuoles with autophagosome features (Deretic 291 
and Levine 2009). In this scenario, the CFTR defect and Bcc infection could have a synergistic 292 
effect down regulating autophagy, which would be consistent with the pronounced delay in the 293 
bacteria-containing vacuole maturation under a functionally impaired CFTR.   294 
 An autophagosome is a compartment that engulfs non-functional
 
organelles and parts of the 295 
cytoplasm, and subsequently delivers these components to the lysosome for degradation and 296 
recovery of essential nutrients during periods of cell starvation or stress. Recent results have 297 
shown that in CFTR-defective murine macrophages, B. cenocepacia persists in vacuoles that 298 
rarely fuse with lysosomes. These infected cells produce higher levels IL-1β than infected 299 
CFTR-normal macrophages (Abdulrahman et al. 2011). It was previously suggested that 300 
intracellular B. cenocepacia reside in autophagosomes that fuse with lysosomes at later stages of 301 
infection (Sajjan et al. 2008). A comparison between infected CFTR-defective and CFTR-normal 302 
macrophages revealed that the autophagy genes are downregulated. However, the CFTR-303 
defective cells contain more bacteria than the CFTR-normal macrophages. Treatment of CFTR-304 
defective macrophages with the autophagy stimulating agent rapamycin markedly decreases B. 305 
cenocepacia infection in vitro by enhancing the clearance of B. cenocepacia via induced 306 
autophagy (Abdulrahman et al. 2011). More importantly rapamycin decreased bacterial burden 307 
and inflammation in the lungs of CF mice, revealing that autophagy can control the fate of the B. 308 
cepacia intracellular infection and the ensuing inflammatory response. 309 
 The mechanism for the link between B. cenocepacia and autophagy in CFTR-defective 310 
macrophages involves the adaptor protein SQSTM1/p62, an ubiquitin binding adaptor protein 311 
that is required for the delivery of ubiquitinated cargo to the autophagosome (Abdulrahman et al. 312 
2012). In CFTR-normal macrophages, p62 depletion and overexpression cause increased and 313 
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decreased bacterial intracellular survival, respectively. However, depletion of p62 in CFTR-314 
defective macrophages results in decreased bacterial survival, whereas overexpression of p62 315 
leads to increased B. cenocepacia intracellular multiplication. Therefore, these studies expose a 316 
strong link between B. cenocepacia infection and the CFTR defect. 317 
 318 
Conclusions 319 
The survival of Bcc bacteria, in particular B. cenocepacia and B. multivorans in macrophages 320 
provides a model system to investigate the interactions of opportunistic pathogens with host cells 321 
responsible for innate immune recognition and beneficial or pathological inflammatory responses 322 
at the molecular level. The elucidation of the details of the survival, especially the ability of B. 323 
cenocepacia to synergize with the CFTR defect and its consequences on the mechanism of 324 
autophagy, provides new avenues to explore novel therapeutic approaches to ameliorate and 325 
control the profuse inflammatory responses triggered by infection and eradicate the bacterial load.  326 
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Legend to Figures 636 
 637 
Fig. 1. Delayed maturation of the B. cenocepacia-containing phagosome. Shortly after 638 
engulfment the B. cenocepacia-containing vacuole acquires LC3 and EEA1 (early endosome 639 
marker). EEA1 is lost upon maturation but instead of rapid acidification the B. cenocepacia-640 
containing vacuole remains with high pH and delays the incorporation of LAMP1 for up to 6 h. 641 
A defective Rab7 is also incorporated to the vacuole. The possibility that during this process the 642 
bacteria escape the vacuole (red dashed lines) and live in the cytosol is not clearly established. 643 
 644 
Fig. 2. Model for the central role of the T6SS in the B. cenocepacia intracellular lifestyle in 645 
macrophages. T6SS effectors are delivered into the cytosol where affect the function of Rho-646 
family GTPases which in turns leads with a defect in the recruitment of soluble components of 647 
the NADPH oxidase to the membrane of the phagosome and defects in actin remodelling 648 
(affecting lamellipodia formation and compromising phagocytosis). These functional defects are 649 
somehow detected by an unknown mechanism and result in the activation of the NLRP3/Pyrin 650 
inflammasomes and subsequent cell death by pyroptosis and sustained inflammation.   651 
652 
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